狼疮性肾炎肾活检中的肾动脉硬化与更高的10年动脉粥样硬化性心血管疾病相关
在209例经活检证实的狼疮性肾炎成人中,36例和49例分别在10年和20年内发生临床动脉粥样硬化性心血管疾病(ASCVD)。肾动脉硬化>25%与10年ASCVD风险升高3倍相关,高区域剥夺指数(>80)与4倍风险相关,较长ACEi暴露与0.65倍风险相关。将肾动脉硬化>25%加入模型可使10年ASCVD风险估计性能从65%提升至80%。
要点
- 肾活检肾动脉硬化>25%与10年ASCVD风险升高3倍相关。
- 高区域剥夺指数(>80)与4倍ASCVD风险相关,较长ACEi暴露与0.65倍风险相关。
- 将肾动脉硬化>25%加入模型使10年ASCVD风险估计性能从65%提升至80%。
核心结论
- 肾动脉硬化>25%、区域剥夺和ACEi暴露可能有助于狼疮性肾炎的ASCVD风险分层。
- 作者认为需要前瞻性研究验证这些发现并指导临床使用。
研究设计与样本
- 纳入经活检证实的狼疮性肾炎成人患者,采用标准Banff分级标准重新阅读诊断时肾活检以分级肾动脉硬化。
- 对临床ASCVD(包括致死和非致死事件)进行裁定,并采集社会人口学、合并症、药物暴露等协变量,使用Cox模型分析10年和20年临床ASCVD相关因素。
主要发现
- 在209例患者中,10年内发生36例临床ASCVD,20年内发生49例。
- 肾动脉硬化>25%与10年ASCVD风险升高3倍相关。
- 高区域剥夺指数(>80)与4倍ASCVD风险相关,较长ACEi暴露与0.65倍ASCVD风险相关。
- 将肾动脉硬化>25%加入模型使10年ASCVD风险估计性能从65%提升至80%。
- 20年ASCVD也观察到类似关联。
关键数值与推荐
- 肾动脉硬化>25%与10年ASCVD风险升高3倍相关。
- 区域剥夺指数>80与4倍ASCVD风险相关。
- 较长ACEi暴露与0.65倍ASCVD风险相关。
- 将肾动脉硬化>25%加入模型使10年ASCVD风险估计性能从65%提升至80%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需要前瞻性研究验证这些发现并指导临床使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with lupus nephritis (LN), including those below age 50, face significantly higher risk of atherosclerotic cardiovascular disease (ASCVD) vs peers. This highlights the need for identifying specific ASCVD risk factors in LN. Renal arteriosclerosis in kidney biopsies (subclinical arteriosclerosis) may be able to predict future clinical ASCVD events. However, renal arteriosclerosis is under-reported in LN biopsies and is not taken into consideration when ASCVD risk is calculated. Therefore, we aimed to systematically grade renal arteriosclerosis in kidney biopsies at LN diagnosis and examined associations with 10-year and 20-year ASCVD occurrence. METHODS: Adults with biopsy-proven LN were included. Clinical ASCVD, including fatal and non-fatal events, were adjudicated. Utilizing standard Banff grading criteria, all biopsies at LN diagnosis were re-read to grade renal arteriosclerosis. Covariables (e.g. socio-demographics, comorbidities, med exposure) were abstracted. Using Cox models, factors (including renal arteriosclerosis) associated with 10-year and 20-year clinical ASCVD were examined. RESULTS: Among 209 patients, 36 and 49 clinical ASCVD occurred within 10 and 20 years. Renal arteriosclerosis (>25%) was associated with 3× higher 10-year ASCVD. High area deprivation index (>80) and longer angiotensin converting enzyme inhibitor (ACEi) exposure were associated with 4× higher and 0.65× lower ASCVD occurrence. Adding renal arteriosclerosis >25% improved model performance for 10-year ASCVD risk estimation from 65% to 80%. Similar associations were seen with 20-year ASCVD. CONCLUSION: Renal arteriosclerosis >25%, area deprivation and ACEi exposure could inform ASCVD risk stratification in LN. Prospective studies should validate findings and inform clinical use.
引用
- Garg S, Astor BC, Lim SS, et al. Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis. Rheumatology (Oxford). 2025. PMID: 39700421. doi:10.1093/rheumatology/keae699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。